Overexpression of CDK1 mRNA and protein has been frequently observed in tumor tissues, potentially driven by gene amplification or activation of upstream transcriptional regulators such as E2F1 and FOXM1 [25]. The gene discussed is CDK1; the disease is neoplasm.